Otsuka Pharmaceutical Factory, Inc.
Clinical trials sponsored by Otsuka Pharmaceutical Factory, Inc., explained in plain language.
A subsidiary of Otsuka Holdings, manufacturing and developing pharmaceutical products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Pig cell transplant trial aims to stop severe low blood sugar in type 1 diabetes Results expected Jun 2027 (estimated)